SOM Biotech
The AI engine Fit Assessment
BetaSOM Biotech leverages machine learning for drug discovery, identifies new patterns for therapeutic development, and actively engages in drug repurposing for orphan diseases.
Blurb
Drug innovation company based on a pioneering AI-based drug discovery technology, that has built a robust pipeline for Orphan CNS diseases.
HQ Location
Barcelona (Spain)
Founded
2009
Employees
11 - 50
Total funding raised
$9.97M
Funding Status
Venture - Series Unknown, January 1, 2021
Subspaces
- Drug Repurposing
For additional information:
info@sombiotech.com